Dossier
generic drugs
Coverage of generic drugs in the Nexus archive.
- When ‘Made in India’ really means ‘Made in China’
India's pharmaceutical industry produces 20% of the world’s generic drugs and supports global vaccine efforts, but faces vulnerabilities highlighted by a 2026 NITI Aayog report. The article questions the authenticity of 'Made in India' labels in the sector, suggesting reliance on Chinese manufacturing.
- STAT+: Want high-quality generic drugs? One expert has ideas on how consumers can trust their supply
Generic drugs, which make up 90% of U.S. prescriptions, face quality issues leading to shortages, with over 60% of shortages due to quality concerns. Kevin Schulman, a Stanford professor, proposes FDA-encouraged independent lab testing to improve trust, citing Valisure's findings of impurities in medicines.